ARTICLE | Clinical News
OMT-28: Ph I started
March 6, 2017 11:49 PM UTC
Omeicos began a double-blind, placebo-controlled, German Phase I trial to evaluate single and multiple ascending doses of oral OMT-28 in up to 100 healthy volunteers....
BCIQ Company Profiles